In previous studies, the tumour targets of ovarian cancer-specific fluorescence imaging included folate receptor alpha (FR-α) [19, 20], follicle-stimulating hormone receptor (FSHR) [2], anti–human epidermal growth factor receptor 2 (HER2) [21] and so on. This evidence concerns the gene FOLR1 and neoplasm.